Michael Strazzella, head of the Firm’s Federal Government Relations practice, was recently quoted in a MarketWatch article about the recent proposal top Democrats in Washington set forth in order to address the rising costs of prescription drugs. In the piece, Michael talks about how this proposal is a good first step in moving the country’s dialogue about the price of medications forward.

Click here to read the article.